A Novel Natural Product-Derived Compound, Vestaine A 1 , Exerts both Pro-Angiogenic and Anti-Permeability Activity via a Different Pathway from VEGF

[...]a treatment to eliminate the fragile vessels by suppressing excess angiogenesis or enhancing vessel maturation would be useful for treating these clinical conditions. Recently, anti-VEGF antibodies have been approved to treat eye diseases such as age-related macular degeneration and cancer, and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cellular physiology and biochemistry 2016-11, Vol.39 (5), p.1905-1918
Hauptverfasser: Ishimoto, Yoko, Hirota-Takahata, Yuki, Kurosawa, Emi, Chiba, Jun, Iwadate, Yuko, Onozawa, Yoshiko, Hasegawa, Toru, Tamura, Akihiro, Tanaka, Masahiro, Kobayashi, Hideki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1918
container_issue 5
container_start_page 1905
container_title Cellular physiology and biochemistry
container_volume 39
creator Ishimoto, Yoko
Hirota-Takahata, Yuki
Kurosawa, Emi
Chiba, Jun
Iwadate, Yuko
Onozawa, Yoshiko
Hasegawa, Toru
Tamura, Akihiro
Tanaka, Masahiro
Kobayashi, Hideki
description [...]a treatment to eliminate the fragile vessels by suppressing excess angiogenesis or enhancing vessel maturation would be useful for treating these clinical conditions. Recently, anti-VEGF antibodies have been approved to treat eye diseases such as age-related macular degeneration and cancer, and show steady efficacy [1, 10, 11]. [...]medicines which accomplish abnormal vessel elimination through mechanisms different from anti-VEGF therapy would be useful to provide other options for patients showing resistance or insufficient response to the anti-VEGF therapy. Power SYBR Green PCR Master Mix and Taqman Gene Expression Master Mix were purchased from Applied Biosystems. After being stirred for 15 min at that temperature, N-acetyl-L-cysteine (1.6 g, 9.67 mmol) was added to the reaction mixture and stirred for 1 h. The reaction mixture was warmed up to room temperature and stirred for 1 h. The reaction was quenched by addition of 1 N HCl (30 ml) at 0°C and extracted with ethyl acetate.
doi_str_mv 10.1159/000447888
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_3040338943</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3040338943</sourcerecordid><originalsourceid>FETCH-LOGICAL-p98t-8152d6efefe9bbf0acc0973dea80ba75778b06fee53f49843286fd3062de55c83</originalsourceid><addsrcrecordid>eNotT8lOwzAUjBBIlOXAHzyJaw1OnMU-Rt1AqkoPVa-VEz-3rlK7OE6h_8EHkwo0h5k5zIwmip5i-hLHmXillKZpwTm_igZxmsREFAW_7jWNM8IFL26ju7bd094WIhlEPyUs3AkbWMjQednA0jvV1YGM0ZsTKhi5w9F1Vg1hjW2QxiKUEMMQJt_oQwuVC7tLiJR2a9wWralBWgWlDYYs0R9QVqYx4QxlHczpIk5GgoSx0Ro92gBLGXZf8gzauwOsJ7PpQ3SjZdPi4z_fR6vpZDV6I_OP2fuonJOj4IHwOEtUjrqHqCpNZV1TUTCFktNKFll_vKK5RsyYTgVPWcJzrRjNE4VZVnN2Hz3_1R69--z6d5u967ztFzeMppQxLlLGfgHe7WbL</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3040338943</pqid></control><display><type>article</type><title>A Novel Natural Product-Derived Compound, Vestaine A 1 , Exerts both Pro-Angiogenic and Anti-Permeability Activity via a Different Pathway from VEGF</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Karger Open Access</source><creator>Ishimoto, Yoko ; Hirota-Takahata, Yuki ; Kurosawa, Emi ; Chiba, Jun ; Iwadate, Yuko ; Onozawa, Yoshiko ; Hasegawa, Toru ; Tamura, Akihiro ; Tanaka, Masahiro ; Kobayashi, Hideki</creator><creatorcontrib>Ishimoto, Yoko ; Hirota-Takahata, Yuki ; Kurosawa, Emi ; Chiba, Jun ; Iwadate, Yuko ; Onozawa, Yoshiko ; Hasegawa, Toru ; Tamura, Akihiro ; Tanaka, Masahiro ; Kobayashi, Hideki</creatorcontrib><description>[...]a treatment to eliminate the fragile vessels by suppressing excess angiogenesis or enhancing vessel maturation would be useful for treating these clinical conditions. Recently, anti-VEGF antibodies have been approved to treat eye diseases such as age-related macular degeneration and cancer, and show steady efficacy [1, 10, 11]. [...]medicines which accomplish abnormal vessel elimination through mechanisms different from anti-VEGF therapy would be useful to provide other options for patients showing resistance or insufficient response to the anti-VEGF therapy. Power SYBR Green PCR Master Mix and Taqman Gene Expression Master Mix were purchased from Applied Biosystems. After being stirred for 15 min at that temperature, N-acetyl-L-cysteine (1.6 g, 9.67 mmol) was added to the reaction mixture and stirred for 1 h. The reaction mixture was warmed up to room temperature and stirred for 1 h. The reaction was quenched by addition of 1 N HCl (30 ml) at 0°C and extracted with ethyl acetate.</description><identifier>ISSN: 1015-8987</identifier><identifier>EISSN: 1421-9778</identifier><identifier>DOI: 10.1159/000447888</identifier><language>eng</language><publisher>Basel: S. Karger AG</publisher><subject>Angiogenesis ; Blood vessels ; Chromatography ; Diabetes ; Hypoxia ; Natural products ; Nitrogen ; Permeability ; Reagents ; Tumors ; Vascular endothelial growth factor</subject><ispartof>Cellular physiology and biochemistry, 2016-11, Vol.39 (5), p.1905-1918</ispartof><rights>2016 The Author(s) Published by S. Karger AG, Basel. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids></links><search><creatorcontrib>Ishimoto, Yoko</creatorcontrib><creatorcontrib>Hirota-Takahata, Yuki</creatorcontrib><creatorcontrib>Kurosawa, Emi</creatorcontrib><creatorcontrib>Chiba, Jun</creatorcontrib><creatorcontrib>Iwadate, Yuko</creatorcontrib><creatorcontrib>Onozawa, Yoshiko</creatorcontrib><creatorcontrib>Hasegawa, Toru</creatorcontrib><creatorcontrib>Tamura, Akihiro</creatorcontrib><creatorcontrib>Tanaka, Masahiro</creatorcontrib><creatorcontrib>Kobayashi, Hideki</creatorcontrib><title>A Novel Natural Product-Derived Compound, Vestaine A 1 , Exerts both Pro-Angiogenic and Anti-Permeability Activity via a Different Pathway from VEGF</title><title>Cellular physiology and biochemistry</title><description>[...]a treatment to eliminate the fragile vessels by suppressing excess angiogenesis or enhancing vessel maturation would be useful for treating these clinical conditions. Recently, anti-VEGF antibodies have been approved to treat eye diseases such as age-related macular degeneration and cancer, and show steady efficacy [1, 10, 11]. [...]medicines which accomplish abnormal vessel elimination through mechanisms different from anti-VEGF therapy would be useful to provide other options for patients showing resistance or insufficient response to the anti-VEGF therapy. Power SYBR Green PCR Master Mix and Taqman Gene Expression Master Mix were purchased from Applied Biosystems. After being stirred for 15 min at that temperature, N-acetyl-L-cysteine (1.6 g, 9.67 mmol) was added to the reaction mixture and stirred for 1 h. The reaction mixture was warmed up to room temperature and stirred for 1 h. The reaction was quenched by addition of 1 N HCl (30 ml) at 0°C and extracted with ethyl acetate.</description><subject>Angiogenesis</subject><subject>Blood vessels</subject><subject>Chromatography</subject><subject>Diabetes</subject><subject>Hypoxia</subject><subject>Natural products</subject><subject>Nitrogen</subject><subject>Permeability</subject><subject>Reagents</subject><subject>Tumors</subject><subject>Vascular endothelial growth factor</subject><issn>1015-8987</issn><issn>1421-9778</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNotT8lOwzAUjBBIlOXAHzyJaw1OnMU-Rt1AqkoPVa-VEz-3rlK7OE6h_8EHkwo0h5k5zIwmip5i-hLHmXillKZpwTm_igZxmsREFAW_7jWNM8IFL26ju7bd094WIhlEPyUs3AkbWMjQednA0jvV1YGM0ZsTKhi5w9F1Vg1hjW2QxiKUEMMQJt_oQwuVC7tLiJR2a9wWralBWgWlDYYs0R9QVqYx4QxlHczpIk5GgoSx0Ro92gBLGXZf8gzauwOsJ7PpQ3SjZdPi4z_fR6vpZDV6I_OP2fuonJOj4IHwOEtUjrqHqCpNZV1TUTCFktNKFll_vKK5RsyYTgVPWcJzrRjNE4VZVnN2Hz3_1R69--z6d5u967ztFzeMppQxLlLGfgHe7WbL</recordid><startdate>20161101</startdate><enddate>20161101</enddate><creator>Ishimoto, Yoko</creator><creator>Hirota-Takahata, Yuki</creator><creator>Kurosawa, Emi</creator><creator>Chiba, Jun</creator><creator>Iwadate, Yuko</creator><creator>Onozawa, Yoshiko</creator><creator>Hasegawa, Toru</creator><creator>Tamura, Akihiro</creator><creator>Tanaka, Masahiro</creator><creator>Kobayashi, Hideki</creator><general>S. Karger AG</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20161101</creationdate><title>A Novel Natural Product-Derived Compound, Vestaine A 1 , Exerts both Pro-Angiogenic and Anti-Permeability Activity via a Different Pathway from VEGF</title><author>Ishimoto, Yoko ; Hirota-Takahata, Yuki ; Kurosawa, Emi ; Chiba, Jun ; Iwadate, Yuko ; Onozawa, Yoshiko ; Hasegawa, Toru ; Tamura, Akihiro ; Tanaka, Masahiro ; Kobayashi, Hideki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p98t-8152d6efefe9bbf0acc0973dea80ba75778b06fee53f49843286fd3062de55c83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Angiogenesis</topic><topic>Blood vessels</topic><topic>Chromatography</topic><topic>Diabetes</topic><topic>Hypoxia</topic><topic>Natural products</topic><topic>Nitrogen</topic><topic>Permeability</topic><topic>Reagents</topic><topic>Tumors</topic><topic>Vascular endothelial growth factor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ishimoto, Yoko</creatorcontrib><creatorcontrib>Hirota-Takahata, Yuki</creatorcontrib><creatorcontrib>Kurosawa, Emi</creatorcontrib><creatorcontrib>Chiba, Jun</creatorcontrib><creatorcontrib>Iwadate, Yuko</creatorcontrib><creatorcontrib>Onozawa, Yoshiko</creatorcontrib><creatorcontrib>Hasegawa, Toru</creatorcontrib><creatorcontrib>Tamura, Akihiro</creatorcontrib><creatorcontrib>Tanaka, Masahiro</creatorcontrib><creatorcontrib>Kobayashi, Hideki</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Cellular physiology and biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ishimoto, Yoko</au><au>Hirota-Takahata, Yuki</au><au>Kurosawa, Emi</au><au>Chiba, Jun</au><au>Iwadate, Yuko</au><au>Onozawa, Yoshiko</au><au>Hasegawa, Toru</au><au>Tamura, Akihiro</au><au>Tanaka, Masahiro</au><au>Kobayashi, Hideki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Novel Natural Product-Derived Compound, Vestaine A 1 , Exerts both Pro-Angiogenic and Anti-Permeability Activity via a Different Pathway from VEGF</atitle><jtitle>Cellular physiology and biochemistry</jtitle><date>2016-11-01</date><risdate>2016</risdate><volume>39</volume><issue>5</issue><spage>1905</spage><epage>1918</epage><pages>1905-1918</pages><issn>1015-8987</issn><eissn>1421-9778</eissn><abstract>[...]a treatment to eliminate the fragile vessels by suppressing excess angiogenesis or enhancing vessel maturation would be useful for treating these clinical conditions. Recently, anti-VEGF antibodies have been approved to treat eye diseases such as age-related macular degeneration and cancer, and show steady efficacy [1, 10, 11]. [...]medicines which accomplish abnormal vessel elimination through mechanisms different from anti-VEGF therapy would be useful to provide other options for patients showing resistance or insufficient response to the anti-VEGF therapy. Power SYBR Green PCR Master Mix and Taqman Gene Expression Master Mix were purchased from Applied Biosystems. After being stirred for 15 min at that temperature, N-acetyl-L-cysteine (1.6 g, 9.67 mmol) was added to the reaction mixture and stirred for 1 h. The reaction mixture was warmed up to room temperature and stirred for 1 h. The reaction was quenched by addition of 1 N HCl (30 ml) at 0°C and extracted with ethyl acetate.</abstract><cop>Basel</cop><pub>S. Karger AG</pub><doi>10.1159/000447888</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1015-8987
ispartof Cellular physiology and biochemistry, 2016-11, Vol.39 (5), p.1905-1918
issn 1015-8987
1421-9778
language eng
recordid cdi_proquest_journals_3040338943
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Karger Open Access
subjects Angiogenesis
Blood vessels
Chromatography
Diabetes
Hypoxia
Natural products
Nitrogen
Permeability
Reagents
Tumors
Vascular endothelial growth factor
title A Novel Natural Product-Derived Compound, Vestaine A 1 , Exerts both Pro-Angiogenic and Anti-Permeability Activity via a Different Pathway from VEGF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T22%3A41%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Novel%20Natural%20Product-Derived%20Compound,%20Vestaine%20A%201%20,%20Exerts%20both%20Pro-Angiogenic%20and%20Anti-Permeability%20Activity%20via%20a%20Different%20Pathway%20from%20VEGF&rft.jtitle=Cellular%20physiology%20and%20biochemistry&rft.au=Ishimoto,%20Yoko&rft.date=2016-11-01&rft.volume=39&rft.issue=5&rft.spage=1905&rft.epage=1918&rft.pages=1905-1918&rft.issn=1015-8987&rft.eissn=1421-9778&rft_id=info:doi/10.1159/000447888&rft_dat=%3Cproquest%3E3040338943%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3040338943&rft_id=info:pmid/&rfr_iscdi=true